2025 Influenza Diagnostic Tests Market Growth Boosting Strategies by Top Key Players Smith & Nephew, Extremity Medical, Stryker Corporation, Zimmer Biomet Holdings, Arthrex

Market Study Report Adds New Research on Influenza Diagnostic Tests Market, Which Is A Detailed Analysis Of This Business Space Inclusive Of The Trends, Competitive Landscape, And The Market Size. Encompassing One Or More Parameters Among Product Analysis, Application Potential, And The Regional Growth Landscape, Influenza Diagnostic Tests Market Also Includes An In-Depth Study Of The Industries Competitive Scenario.

Increase in research funding and recent technological developments for influenza diagnostic tests will be a major market growth driver. Recent technological advancements has resulted in growing use of rapid influenza diagnostic tests. Rapid influenza diagnostic test (RIDT) segment is estimated to witness substantial growth over the forecast period. These tests are antigen detection assays that help in detecting influenza in around 15 minutes with high accuracy and specificity. RIDT is capable of detecting the presence of influenza antigens in the samples and display the result precisely. Hence, growing application of rapid influenza diagnostic tests will enhance the business growth in the forthcoming years.

Request a sample of this premium report titled Influenza Diagnostic Tests Market 2019 - 2025 at https://www.marketstudyreport.com/request-a-sample/2212520?utm_source=openpr.com&utm_medium=Ram

Influenza Diagnostic Tests Market will exceed USD 1.5 Billion by 2025; as per a new research report. Influenza diagnostic tests market is projected to witness significant growth over the upcoming years. The rapid growth is attributed to rise in prevalence of influenza and related chronic diseases across the globe. As per the recent statistics published by Centers for Disease Control and Prevention (CDC), influenza is the cause for around 12,000 to 79,000 deaths annually in the U.S. Moreover, growing awareness among the population regarding several diagnostic tests for early detection and prevention of influenza will result in high demand and adoption of influenza diagnostic tests, augmenting overall industry growth.

Some of the notable companies operating in influenza diagnostic tests market include Extremity Medical, Stryker Corporation, Zimmer Biomet Holdings, Arthrex, Smith & Nephew Plc, Integra LifeSciences Holdings Corporation, Acumed LLC., Tornier N.V. and Wright Medical Technology. Major strategies adopted by these industry players include strategic collaborations, mergers, partnerships, and innovative product launch to expand their business product portfolio and consolidate market position.

However, strict regulatory guidelines for new diagnostic test approvals and several inconsistencies in sensitivity and specificity of influenza diagnostic tests will impede the influenza diagnostics tests market growth in the near future.

Influenza diagnostic tests for Type A is forecasted to grow at 7.0% over the estimation period. Rise in incidence of influenza across the globe will positively impact the market growth. Influenza A is communicable respiratory disease that is quite prevalent in the developing regions of Asia Pacific and Latin America. The major reason for Influenza A prevalence is viral infection caused by avian flu or bird flu. The most common host for large variety of influenza A viruses are wild aquatic birds. These viruses are transmitted from wild aquatic birds to poultry that may cause an outbreak or give rise to human influenza epidemic. Hence, increase in influenza prevalence will result in high demand for influenza diagnostic tests, thus augmenting the market growth.

Influenza diagnostic tests using traditional diagnostic method was valued at around USD 594.8 million in the year 2018. Traditional diagnostic tests are gaining significance across the globe owing to rapid detection of influenza antigens by the rapid influenza diagnostic test (RIDT) and display of accurate results in a qualitative format. Rapid influenza diagnostic tests (RIDT) yield results in relevant time slot of less than 15 minutes. Hence, numerous advantages of traditional diagnostic methods will lead to considerable market growth.

Influenza diagnostic tests in pediatric is estimated to grow at 7.7% over the projection period. Increase in the burden of influenza in pediatrics will drive the growth of influenza testing market over the forthcoming years. According to the Centers for Disease Control and Prevention (CDC), morbidity and mortality related to influenza is high among the children under two years of age than adults. Hence, growing influenza prevalence in children will augment the segmental growth during the foreseeable future.

Use of influenza diagnostic tests in hospitals was valued at around USD 278.3 million in the year 2018. Hospitals provide several advanced and state-of-art facilities for proper influenza testing. Moreover, influenza diagnosis is suggested for in-patients with suspected influenza. Growing preference of patients for diagnostics in hospitals in developing nations over other healthcare facilities owing to rising awareness of early disease detection will further augment market growth.

U.S. influenza diagnostic tests market is expected to witness significant growth at 6.3% over the forecast period due to presence of skilled professionals, well-developed healthcare infrastructure and technological advancements coupled with growing influenza prevalence in the country. Additionally, growing initiatives by the government to manufacture advanced technologies with the aim to deliver efficient results for influenza testing is another major reason to escalate market growth.

China influenza diagnostic tests market was valued at around USD 70.4 million in the year 2018. The growth of the market is attributed to rise in prevalence of influenza along with several initiatives taken by the government to raise awareness regarding influenza diagnostics and treatment. As per the World Health Organization (WHO), China is considered to be one of the major countries with high influenza prevalence rate. Hence, aforementioned factors will play a significant role in augmenting China market growth across the forecast timeframe.

Request a discount on standard prices of this premium report titled Influenza Diagnostic Tests Market 2019 - 2025 at https://www.marketstudyreport.com/check-for-discount/2212520?utm_source=openpr.com&utm_medium=Ram

Report Content

Chapter 1. Methodology

1.1. Methodology

1.2. Market definition

1.3. Forecast parameters

1.4. Data sources

1.4.1. Secondary

1.4.1.1. Paid sources

1.4.1.2. Unpaid sources

1.4.2. Primary

Chapter 2. Executive Summary

2.1. Influenza diagnostic tests industry 3600 synopsis, 2014 - 2025 (USD Million)

2.1.1. Business trends

2.1.2. Influenza type trends

2.1.3. Test type trends

2.1.4. Patient trends

2.1.5. End-use trends

2.1.6. Regional trends

Chapter 3. Influenza Diagnostic Tests Industry Insights

3.1. Industry segmentation

3.2. Industry landscape, 2014 - 2025 (USD Million)

3.3. Industry impact factors

3.3.1. Growth drivers

3.3.1.1. Growing prevalence of influenza

3.3.1.2. Increase in R&D activities

3.3.1.3. Rise in demand for rapid diagnostic tests

3.3.2. Industry pitfalls & challenges

3.3.2.1. Lack of skilled professionals

3.3.2.2. Stringent regulatory guidelines

3.4. Growth potential analysis

3.4.1. By influenza type

3.4.2. By test type

3.4.3. By patient

3.4.4. By end-use

3.5. Porter's analysis

3.6. Competitive landscape, 2018

3.6.1. Strategy dashboard

3.7. PESTEL analysis

Chapter 4. Influenza Diagnostic Tests Market, By Influenza Type

4.1. Global influenza diagnostic tests market share, by influenza type, 2018 & 2025

4.2. Type A Flu

4.2.1. Market size, by region, 2014 - 2025 (USD Million)

4.3. Type B Flu

4.3.1. Market size, by region, 2014 - 2025 (USD Million)

Chapter 5. Influenza Diagnostic Tests Market, By Test Type

5.1. Global influenza diagnostic tests market share, by test type, 2018 & 2025

5.2. Traditional diagnostic test

5.2.1. Market size, by region, 2014 - 2025 (USD Million)

5.2.2. Rapid Influenza Diagnostic Test (RIDT)

5.2.2.1. Market size, by region, 2014 - 2025 (USD Million)

5.2.3. Direct Fluorescent Antibody Test (DFAT)

5.2.3.1. Market size, by region, 2014 - 2025 (USD Million)

5.2.4. Viral culture

5.2.4.1. Market size, by region, 2014 - 2025 (USD Million)

5.2.5. Serological assay

5.2.5.1. Market size, by region, 2014 - 2025 (USD Million)

5.3. Molecular diagnostic assay

5.3.1. Market size, by region, 2014 - 2025 (USD Million)

5.3.2. RT-PCR

5.3.2.1. Market size, by region, 2014 - 2025 (USD Million)

5.3.3. Loop-mediated Isothermal Amplification-based Assay (LAMP)

5.3.3.1. Market size, by region, 2014 - 2025 (USD Million)

5.3.4. Nucleic Acid Sequence-based Amplification Test (NASBAT)

5.3.4.1. Market size, by region, 2014 - 2025 (USD Million)

5.3.5. Simple Amplification-based Assay (SAMBA)

5.3.5.1. Market size, by region, 2014 - 2025 (USD Million)

5.3.6. Others

5.3.6.1. Market size, by region, 2014 - 2025 (USD Million)

Chapter 6. Influenza Diagnostic Tests Market, By Patient

6.1. Global influenza diagnostic tests market share, by patient, 2018 & 2025

6.2. Pediatric

6.2.1. Market size, by region, 2014 - 2025 (USD Million)

6.2.2. 0 to 4 years

6.2.2.1. Market size, by region, 2014 - 2025 (USD Million)

6.2.3. 5 to 17 years

6.2.3.1. Market size, by region, 2014 - 2025 (USD Million)

6.3. Adult

6.3.1. Market size, by region, 2014 - 2025 (USD Million)

6.3.2. 18 to 49 years

6.3.2.1. Market size, by region, 2014 - 2025 (USD Million)

6.3.3. 50 to 64 years

6.3.3.1. Market size, by region, 2014 - 2025 (USD Million)

6.3.4. 65+ years

6.3.4.1. Market size, by region, 2014 - 2025 (USD Million)

Chapter 7. Influenza Diagnostic Tests Market, By End-use

7.1. Global influenza diagnostic tests market share by end-use, 2018 & 2025

7.2. Hospitals

7.2.1. Market size, by region, 2014 - 2025 (USD Million)

7.3. Diagnostics centers

7.3.1. Market size, by region, 2014 - 2025 (USD Million)

7.4. Research laboratories

7.4.1. Market size, by region, 2014 - 2025 (USD Million)

7.5. Others

7.5.1. Market size, by region, 2014 - 2025 (USD Million)

Chapter 8. Influenza Diagnostic Tests Market, By Region

Chapter 9. Company Profiles

Contact Us:

Market Study Report LLC

4 North Main Street,

Selbyville, Delaware 19975

USA

Phone: 1-302-273-0910

US Toll Free: 1-866-764-2150

Email: sales@marketstudyreport.com

Website: https://www.marketstudyreport.com

Blog: https://www.marketstudyreport.com/blog

About Us:

Marketstudyreport.com allows you to manage and control all corporate research purchases to consolidate billing and vendor management. You can eliminate duplicate purchases and customize your content and license management.

This release was published on openPR.